Influence of febuxostat and allopurinol on renal function

Influence of febuxostat and allopurinol on renal function - Influence of febuxostat and allopurinol on renal function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008168

Enrollment

Registered

2012-06-14

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who is taking allopurinol for hyperuricemia

Interventions

Switch from Allopurinol to Febuxostat Continuation of Allopurinol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who is taking Allopurinol for hyperuricemia 2) Patients from whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients from whom informed consent was not obtained

Design outcomes

Primary

Measure	Time frame
1) Serum uric acid 2) Urinary Albumin	—

Secondary

Measure	Time frame
1) serum Cr 2) eGFR 3) cystatin C 4) Oxidized LDL 5) T-cho, TG, LDL,HDL 6)PWV 7)BNP, EF, LVM 8) side effects	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Nihon University school of medicine Department of Cardiovascular Surgery

asezai.med@gmail.com03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026